Functional analysis of the TGFβ receptor/Smad pathway through gene ablation in mice

International Journal of Developmental Biology

Volumn 44, Issue 3, 2000, Pages 253-265

  Goumans, Marie José ^a   Mummery, Christine ^b  

^a NETHERLANDS CANCER INSTITUTE   (Netherlands)

^b HUBRECHT INSTITUTE   (Netherlands)

Author keywords

Gene ablation; Mouse; Serine threonine kinase receptors; Smads; TGF ligands

Indexed keywords

PROTEIN SERINE THREONINE KINASE; RECEPTOR PROTEIN; SMAD PROTEIN; TRANSFORMING GROWTH FACTOR BETA RECEPTOR; DNA BINDING PROTEIN; TRANSACTIVATOR PROTEIN;

ANGIOGENESIS; CELL FUNCTION; ECTODERM; EMBRYO DEVELOPMENT; GASTRULATION; GENE TARGETING; HEMATOPOIESIS; MOUSE; NONHUMAN; PHENOTYPE; PRIORITY JOURNAL; RECEPTOR BINDING; RECEPTOR INTRINSIC ACTIVITY; REVIEW; SIGNAL TRANSDUCTION; ANIMAL; BIOLOGICAL MODEL; CARDIOVASCULAR SYSTEM; EMBRYO; GASTRULA; GENE DOSAGE; GENETICS; METABOLISM; PHYSIOLOGY; PRENATAL DEVELOPMENT;

ANIMALS; CARDIOVASCULAR SYSTEM; DNA-BINDING PROTEINS; EMBRYO; GASTRULA; GENE DOSAGE; MICE; MODELS, BIOLOGICAL; RECEPTORS, TRANSFORMING GROWTH FACTOR BETA; SIGNAL TRANSDUCTION; TRANS-ACTIVATORS;

EID: 0033625416     PISSN: 02146282     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (91)

1. ARTHUR, H.M., URE, J., SMITH, A.J.H., RENFORTH, G., WILSON, D.I.,TORSNEY, E., CHARLTON, R., PARUMS, D.V., JOWETT, T., MARCHUK, D.A., BURN, J. and DIAMOND, A.G. (1999). Endoglin, an ancillary TGFβ receptor, is required for extraembryonic angiogenesis and plays an important role in heart development. Dev. Biol.: 217: 42-53.
2. ASHCROFT, G.S., YANG, X., GLICK, A.B., WEINSTEIN, M., LETTERIO, J.L., MIZEL, D.E., ANZANO, M., GREENWELL-WILD, T., WAHL, S.M., DENG, C. and ROBERTS, A.B. (1999). Mice lacking Smad3 show accelerated wound healing and an impaired local inflammatory response. Nat. Cell Biol. 5:560-266.
3. ATTISANO, L. and WRANA, J.L. (1998). Mads and Smads in TGF β signalling. Curr. Opin. Cell Biol. 10:188-194.
4. BAKER, J.C. and HARLAND, R.M. (1996). A novel mesoderm inducer, Madr2, functions in the activin signal transduction pathway. Genes Dev. 10:1880-1889.
5. BAUR, ST., MAI, J.J. and DYMECKI, S.M. (2000). Combinatorial signaling through BMP receptor IB and GDF5: shaping of the distal mouse limb and the genetics of distal limb diversity. Development 127:605-619.
6. BONYADI, M., RUSHOLME, S.A., COUSINS, F.M., SU, H.C., BIRON, C.A., FARRALL, M. and AKHURST, R.J. (1997). Mapping of a major genetic modifier of embryonic lethality in TGF β 1 knockout mice. Nat. Genet. 15:207-211
7. BOURDEAU, A., DUMONT, D.J. and LETARTE, M. (1999). A murine model of hereditary hemorrhagic telangiectasia. J. Clin. Invest. 104:1343-1351.
8. CHANG, H., HUYLEBROECK, D., VERSCHUEREN, K., GUO, Q., MATZUK, M.M. and ZWIJSEN, A. (1999). Smad5 knockout mice die at mid-gestation due to multiple embryonic and extraembryonic defects. Development 126:1631-1642.
9. CHANG, H., ZWIJSEN, A., VOGEL, H., HUYLEBROECK, D. and MATZUK, M.M. (2000). Smad5 is essential for left-right asymmetry in mice. Dev. Biol. 219:71-78.
10. CHEN, Y.G. and MASSAGUÉ, J. (1999). Smad1 recognition and activation by the ALK1 group of transforming growth factor-β family receptors. J. Biol. Chem. 274:3672-3677.
11. CHRISTIAN, J.L. and NAKAYAMA, T. (1999). Can't get no SMADisfaction: Smad proteins as positive and negative regulators of TGF-β family signals. BioEssays 21:382-390.
12. COLLIGNON, J., VARLET, I. and ROBERTSON, E.J. (1996). Relationship between asymmetric nodal expression and the direction of embryonic turning. Nature 381:155-158.
13. CONLON, F.L., LYONS, K.M., TAKAESU, N., BARTH, K.S., KISPERT, A., HERRMANN, B. and ROBERTSON, EJ. (1994). A primary requirement for nodal in the formation and maintenance of the primitive streak in the mouse. Development 120:1919-1928.
14. DATTO, M.B., FREDERICK, J.P., PAN, L., BORTON, A J., ZHUANG, Y. and WANG, X.F. (1999). Targeted disruption of Smad3 reveals an essential role in transforming growth factor β-mediated signal transduction. Mol. Cell. Biol. 19:2495-2504.
15. DEWULF, N., VERSCHUEREN, K., LONNOY, O., MOREN, A., GRIMSBY, S., VANDE SPIEGLE, K., MIYAZONO, K., HUYLEBROECK, D. and TEN DIJKE, P. (1995). Distinct spatial and temporal expression patterns of two type I receptors for bone morphogenetic proteins during mouse embryogenesis. Endocrinology 136:2652-2663.
16. DICKSON, M.C., MARTIN, J.S., COUSINS, F.M., KULKARNI, A.B., KARLSSON, S. and AKHURST, R.J. (1995). Defective haematopoiesis and vasculogenesis in transforming growth factor-β 1 knock out mice. Development 121:1845-1854.
17. DUDLEY, A.T., LYONS, K.M. and ROBERTSON, E.J. (1995). A requirement for bone morphogenetic protein-7 during Development of the mammalian kidney and eye. Genes Dev. 9:2795-2807.
18. DUNN, N.R., WINNIER, G.E., HARGETT, L.K., SCHRICK, J.J., FOGO, A.B. and HOGAN, B.L. (1997). Haploinsufficient phenotypes in Bmp4 heterozygous null mice and modification by mutations in Gli3 and Alx4. Dev. Biol. 188:235-247.
19. DYSON, S. and GURDON, J.B. (1997). Activin signalling has a necessary function in Xenopus early development. Curr. Biol. 7:81-84.
20. FERGUSON, E.L. and ANDERSON, K.V. (1992). Decapentaplegic acts as a morphogen to organize dorsal-ventral pattern in the Drosophila embryo. Cell 71:451-461.
21. FRANZEN, P., TEN DIJKE, P., ICHIJO, H., YAMASHITA, H., SCHULZ, P., HELDIN, C.H. and MIYAZONO, K. (1993). Cloning of a TGF β type I receptor that forms a heteromeric complex with the TGF β type II receptor. Cell 75:661-692.
22. GALVIN, K.M., DONOVAN, M.J., LYNCH, C.A., MEYER, R.I., PAUL, R.J., LORENZ, J.N., FAIRCHILD-HUNTRESS, V., DIXON, K.L., DUNMORE, J.H., GIMBRONE, M.A. JR., FALB, D. and HUSZAR, D. (2000). A role for smad6 in Development and homeostasis of the cardiovascular system. Nat. Genet. 24:171-174.
23. GOUGOS, A. and LETARTE, M. (1990). Primary structure of endoglin, an RGD-containing glycoprotein of human endothelial cells. J. Biol. Chem. 265:8361-8364.
24. GOUMANS, M.-J., ZWIJSEN, A., VAN ROOIJEN, M.A., HUYLEBROECK, D., ROELEN, B.A. and MUMMERY, C.L. (1999). Transforming growth factor-β signalling in extraembryonic mesoderm is required for yolk sac vasculogenesis in mice. Development 126:3473-3483.
25. GREEN, J.B., NEW, H. V. and SMITH, J. C. (1992). Responses of embryonic Xenopus cells to activin and FGF are separated by multiple dose thresholds and correspond to distinct axes of the mesoderm. Cell 71:731-739.
26. GU, Z., NOMURA, M., SIMPSON, B.B., LEI, H., FEIJEN, A., VAN DEN EIJNDEN-VAN RAAIJ, J., DONAHOE, P.K. and LI, E. (1998). The type I activin receptor ActRIB is required for egg cylinder organization and gastrulation in the mouse. Genes Dev. 12:844-857.
27. GU, Z., REYNOLDS, E.M., SONG, J., LEI, H., FEIJEN, A., YU, L., HE, W., MACLAUGHLIN, D.T., VAN DEN EIJNDEN-VAN RAAIJ, J., DONAHOE, P.K. and LI, E. (1999). The type I serine/threonine kinase receptor ActRIA (ALK2) is required for gastrulation of the mouse embryo. Development 126:2551-2561.
28. GURDON, J.B., HARGER, P., MITCHELL, A. and LEMAIRE, P. (1994). Activin signalling and response to a morphogen gradient. Nature 371:487-492.
29. HATA, A., LAGNA, G., MASSAGUÉ, J. and HEMMATI-BRIVANLOU, A. (1998) Smad6 inhibits BMP/Smad1 signaling by specifically competing with the Smad4 tumor suppressor. Genes Dev. 12:186-197.
30. HELDIN, C.-H., MIYAZONO, K. and TEN DIJKE, P. (1997). TGF-β signalling from cell membrane to nucleus through SMAD proteins. Nature 390:465-471.
31. HEYER, J., ESCALANTE-ALCALDE, D., LIA, M., BOETTINGER, E., EDELMANN, W., STEWART, C.L. and KUCHERLAPATI, R. (1999). Postgastrulation Smad2-deficient embryos show defects in embryo turning and anterior morphogenesis. Proc. Natl. Acad. Sci. USA 96:12595-12600.
32. HOWELL, M., ITOH, F., PIERREUX, C.E., VALGEIRSDOTTIR, S., ITOH, S., TEN DIJKE, P. and HILL, C.S. (1999). Xenopus Smad4β is the Co-Smad component of developmentally regulated transcription factor complexes responsible for induction of early mesodermal genes. Dev. Biol. 214:354-369.
33. IMAMURA, T., TAKASE, M., NISHIHARA, A., OEDA, E., HANAI, J., KAWABATA, M. and MIYAZONO, K. (1997). Smad6 inhibits signalling by the TGF-β superfamily. Nature 389:622-626.
34. ITOH, S., LANDSTROM, M., HERMANSSON, A., ITOH, F., HELDIN, C.H., HELDIN, N.E. and TEN DIJKE, P. (1998). Transforming growth factor betal induces nuclear export of inhibitory Smad7. J. Biol. Chem. 273:29195-29201.
35. JOHNSON, D.W., BERG, J.N., BALDWIN, M.A., GALLIONE, C.J., MARONDEL, I., YOON, S.J., STENZEL, T.T., SPEER, M., PERICAK-VANCE, M.A., DIAMOND, A., GUTTMACHER, A.E., JACKSON, C.E., ATTISANO, L., KUCHERLAPATI, R., PORTEOUS, M.E. and MARCHUK, D.A. (1996). Mutations in the activin receptor-like kinase 1 gene in hereditary haemorrhagic telangiectasia type 2. Nat. Genet. 13:189-195.
36. KAARTINEN, V., VONCKEN, J.W., SHULER, C., WARBURTON, D., BU, D., HEISTERKAMP, N. and GROFFEN, J. (1995). Abnormal lung development and cleft palate in mice lacking TGF-beta 3 indicates defects of epithelial-mesenchymal interaction. Nat. Genet. 11:415-421.
37. KALLAPUR, S, ORMSBY, I. and DOETSCHMAN, T. (1999). Strain dependency of TGFβ1 function during embryogenesis. Mol. Reprod. Dev. 52:341 -349.
38. KINGSLEY, D.M. (1994). The TGF-β superfamily: new members, new receptors and new genetic tests of function in different organisms. Genes Dev. 2:133-146.
39. KULKARNI, A.B., HUH, C.G., BECKER, D., GEISER, A., LYGHT, M., FLANDERS, K.C., ROBERTS, A.B., SPORN, M.B., WARD, J.M. and KARLSSON, S. (1993). Transforming growth factor β 1 null mutation in mice causes excessive inflammatory response and early death. Proc. Natl. Acad. Sci. USA 90:770-774.
40. LAWSON, K.A., DUNN, N.R., ROELEN, B.A., ZEINSTRA, L.M., DAVIS, A.M., WRIGHT, C.V., KORVING, J.P. and HOGAN, B.L. (1999). Bmp4 is required for the generation of primordial germ cells in the mouse embryo. Genes Dev. 13:424-436.
41. LETTERIO, J.J., GEISER, A.G., KULKARNI, A.B., DANG, H., KONG, L., NAKABAYASHI, T., MACKALL, C.L., GRESS, R.E. and ROBERTS, A.B. (1996). Autoimmunity associated with TGF-beta1-deficiency in mice is dependent on MHC class II antigen expression. J. Clin. Invest. 98:2109-2119.
42. LETTERIO, J.J., GEISER, A.G., KULKARNI, A.B., ROCHE, N.S., SPORN, M.B. and ROBERTS, A.B. (1994). Maternal rescue of transforming growth factor-β 1 null mice. Science 264:1936-1938.
43. LI, D.Y., SORENSEN, LK., BROOKE, B.S., URNESS, L.D., DAVIS, E.C., TAYLOR, D.G., BOAK, B.B. and WENDEL, O.P. (1999). Defective angiogenesis in mice lacking endoglin. Science 284:1534-1537.
44. LIN, H.Y., WANG, X.-F., NG-EATON, E., WEINBERG, R.A. and LODISH, H.F. (1992). Expression cloning of the TGF-β type II receptor, a functional transmembrane serine/threonine kinase. Cell 68:775-785.
45. LOPEZ-CASILLAS, F., WRANA, J.L. and MASSAGUÉ, J. (1993). Betaglycan presents ligand to the TGF β signaling receptor. Cell 73:1435-1444.
46. LUO, G., HOFMANN, C., BRONCKERS, A.L., SOHOCKI, M., BRADLEY, A. and KARSENTY, G. (1995). BMP-7 is an inducer of nephrogenesis and is also required for eye development and skeletal patterning. Genes Dev. 9:2808-2820.
47. LUX, A., ATTISANO, L. and MARCHUK, D.A. (1999). Assignment of transforming growth factor β 1 and β 3 and a third new ligand to the type I receptor ALK-1. J. Biol. Chem. 274:9984-9992.
48. MACIAS-SILVA, M., HOODLESS, P.A., TANG, S.J., BUCHWALD, M. and WRANA, J.L. (1998). Specific activation of Smad1 signaling pathways by the BMP7 type I receptor, ALK2. J. Biol. Chem. 273: 25628-25636.
49. MASSAGUÉ, J. (1998). TGF-β signal transduction. Ann. Rev. Biochem. 67:753-791.
50. MASUYAMA, N., HANAFUSA, H., KUSAKABE, M., SHIBUYA, H. and NISHIDA, E. (1999). Identification of two Smad4 proteins in Xenopus. Their common and distinct properties. J. Biol. Chem. 274:12163-12170.
51. MATZUK, M.M., KUMAR, T.R. and BRADLEY, A. (1995). Different phenotypes for mice deficient in either activins or activin receptor type II. Nature 374:356-360.
52. MCALLISTER, K.A., GROGG, K.M., JOHNSON, D.W., GALLIONE, C.J., BALDWIN, M.A., JACKSON, C.E., HELMBOLD, E.A., MARKEL, D.S., MCKINNON, W.C., MURRELL, J. , MCCORMICK, M.K., PERICAK-VANCE, M.A., HENTINK, P., OOSTRA, B.A., HAITJEMA, T., WESTERMAN, C.J.J., PORTEOUS, M.E., GUTTMACHER, A.E., LETARTE, M. and MARCHUK, D.A. (1994). Endoglin, a TGF-beta binding protein of endothelial cells, is the gene for hereditary hemorrhagic telangiectasia type 1. Nat. Genet. 8:345-351.
53. MISHINA, Y., CROMBIE, R., BRADLEY, A. and BEHRINGER, R.R. (1999). Multiple roles for activin-like kinase-2 signaling during mouse embryogenesis. Dev. Biol. 213:314-326.
54. MISHINA, Y., SUZUKI, A., UENO, N. and BEHRINGER, R.R. (1995). Bmpr encodes a type I bone morphogenetic protein receptor that is essential for gastrulation during mouse embryogenesis. Genes Dev. 9:3027-3037.
55. MIYAZONO, K. (1999). Signal transduction by bone morphogenetic protein receptors: functional roles of Smad proteins. Bone 25:91-93.
56. MUMMERY, C.L. and VAN DEN EIJNDEN-VAN RAAIJ, A,J. (1999). Developmental tumours, early differentiation and the transforming growth factor beta superfamily. Int. J. Dev. Biol. 43:693-709.
57. NAKAO, A., AFRAKHTE, M., MORÉN, A., NAKAYAMA, T., CHRISTIAN, J.L., HEUCHEL, R., ITOH, S., KAWABATA, M., HELDIN, N.E., HELDIN, C.H. and TEN DIJKE, P. (1997). Identification of Smad7, a TGFβ-inducible antagonist of TGF-β signalling. Nature 389:631-5.
58. NOMURA, M. and LI, E. (1998). Smad2 role in mesoderm formation, left-right patterning and craniofacial development. Nature 393:786-790.
59. OH, S.P. and LI, E. (1997). The signaling pathway mediated by the type MB activin receptor controls axial patterning and lateral asymmetry in the mouse. Genes Dev. 11:1812-1826.
60. OH, S.P., SEKI, T., GOSS, K.A., IMAMURA, T., YI, Y., DONAHOE, P.K., LI, L., MIYAZONO, K., TEN DIJKE, P., KIM, S. and LI, E. (2000). Activin receptor like kinase 1 (ALK-1) modulates TGFβ1 signalling in regulation of angiogenesis. Proc. Natl. Acad. Sci. USA 97:2626-2631.
61. OSHIMA, M., OSHIMA, H. and TAKETO, M.M. (1996). TGF-β receptor type II deficiency results in defects of yolk sac hematopoiesis and vasculogenesis. Dev. Biol. 179:297-302.
62. PROETZEL, G., PAWLOWSKI, S.A., WILES, M.V., YIN, M., BOIVIN, G.P., HOWLES, P.N., DING, J., FERGUSON, M.W. and DOETSCHMAN, T. (1995). Transforming growth factor-beta 3 is required for secondary palate fusion. Nat. Genet. 11:409-414.
63. ROBERTS, A.B. and SPORN, M.B. (1990). The transforming growth factors βs. In Peptide growth factors and their receptors. (Eds. M.B. Sporn and A.B. Roberts) Springer-Verlag, New York. pp. 419-472.
64. ROELEN, B.A., GOUMANS, M.J., ZWIJSEN, A. and MUMMERY, C.L. (1998). Identification of two distinct functions for TGF-β in early mouse development. Differentiation 64:19-31.
65. SANFORD, L.P., ORMSBY, I., GITTENBERGER-DE GROOT, A.C., SARIOLA, H., FRIEDMAN, R., BOIVIN, G.P., CARDELL, E.L. and DOETSCHMAN, T. (1997). TGFbeta2 knockout mice have multiple developmental defects that are non-overlapping with other TGFbeta knockout phenotypes. Development 124:2659-2670.
66. SCHREWE, H., GENDRON-MAGUIRE, M., HARBISON, M.L. and GRIDLEY, T. (1994). Mice homozygous for a null mutation of activin beta B are viable and fertile. Mech. Dev. 47:43-51.
67. SCHULTE-MERKER, S., SMITH, U.C. and DALE, L. (1994). Effects of truncated activin and FGF receptors and of follistatin on the inducing activities of BVg1 and activin: does activin play a role in mesoderm induction? E.M.B.O. J. 13:3533-3541.
68. SHULL, M.M., ORMSBY, I., KIER, A.B., PAWLOWSKI, S., DIEBOLD, R.J., YIN, M., ALLEN, R., SIDMAN, C., PROETZEL, G., CALVIN, D., ANNUNZIATA, N. and DOETSCHMAN, T. (1992). Targeted disruption of the mouse transforming growth factor-β 1 gene results in multifocal inflammatory disease. Nature 359:693-699.
69. SIRARD, C., DE LA POMPA, J.L., ELIA, A., ITIE, A., MIRTSOS, C., CHEUNG, A., HAHN, S., WAKEHAM, A., SCHWARTZ, L., KERN, S.E., ROSSANT, J. and MAK, T. W. (1998). The tumor suppressor gene Smad4/Dpc4 is required for gastrulation and later for anterior development of the mouse embryo. Genes Dev. 12:107-119.
70. SOLLOWAY, M.J. and ROBERTSON, E.J. (1999). Early embryonic lethality in Brnp5;Bmp7 double mutant mice suggests functional redundancy within the 60A subgroup. Development 126:1753-1768.
71. SONG, J., OH, S.P., SCHREWE, H., NOMURA, M., LEI, H., OKANO, M., GRIDLEY, T. and LI, E. (1999). The type II activin receptors are essential for egg cylinder growth, gastrulation and rostral head development in mice. Dev. Biol. 213:157-169.
72. SOUCHELNYTSKYI, S., NAKAYAMA, T., NAKAO, A., MOREN, A., HELDIN, C.H., CHRISTIAN, J.L. and TEN DIJKE, P. (1998). Physical and functional interaction of murine and Xenopus Smad7 with bone morphogenetic protein receptors and transforming growth factor-β receptors. J. Biol. Chem. 273:25364-25370.
73. TEN DIJKE, P., MIYAZONO, K. and HELDIN, C.H. (2000). Signaling inputs converge on nuclear effectors in TGFβ signaling. Trends Biochem. Sci. 25:64-70.
74. TEN DIJKE, P., YAMASHITA, H., ICHIJO, H., FRANZEN, P., LAIHO, M., MIYAZONO, K. and HELDIN, C.H. (1994a). Characterization of type I receptors for transforming growth factor-β and activin. Science 264:101-104.
75. TEN DIJKE, P., YAMASHITA, H., SAMPATH, T.K., REDDI, A.H., ESTEVEZ, M., RIDDLE, D.L., ICHIJO, H., HELDIN, C.H. and MIYAZONO, K. (1994b). Identification of type I receptors for osteogenicprotein-1 and bone morphogenetic protein-4. J. Biol. Chem. 269:16985-16988.
76. TOPPER, J.N., CAI, J., QIU, Y., ANDERSON, K.R., XU, Y.Y., DEEDS, J.D., FEELEY, R., GIMENO, C.J., WOOLF, E.A., TAYBER, O., MAYS, G.G., SAMPSON, B.A., SCHOEN, F.J., GIMBRONE, M.A. JR. and FALB, D. (1997). Vascular MADs: two novel MAD-related genes selectively inducible by flow in human vascular endothelium. Proc. Natl. Acad. Sci. USA 94:9314-9319.
77. VARLET, I., COLLIGNON, J. and ROBERTSON, E.J. (1997). Nodal expression in the primitive endoderm is required for specification of the anterior axis during mouse gastrulation. Development 124:1033-1044.
78. VASSALLI, A., MATZUK, M.M., GARDNER, H.A., LEE, K.F. and JAENISCH, R. (1994). Activin/inhibin beta B subunit gene disruption leads to defects in eyelid development and female reproduction. Genes Dev. 8:414-427.
79. VERSCHUEREN, K. and HUYLEBROECK, D. (1999). Remarkable versatility of Smad proteins in the nucleus of transforming growth factor-beta activated cells. Cytokine Growth Factor Rev. 10:187-199.
80. WALDRIP, W.R., BIKOFF, E.K., HOODLESS, P.A., WRANA, J.L. and ROBERTSON, E.J. (1998). Smad2 signaling in extraembryonic tissues deteirmines anterior-posterior polarity of the early mouse embryo. Cell 92:797-808.
81. WEINSTEIN, M., YANG, X., LI, C., XU, X., GOTAY, J. and DENG, C.X. (1998). Failure of egg cylinder elongation and mesoderm induction in mouse embryos lacking the tumor suppressor Smad2. Proc. Natl. Acad. Sci. USA 95:9378-9383.
82. WILKINSON, D.G., BHATT, S. and HERRMANN, B.G. (1990). Expression pattern of the mouse T gene and its role in mesoderm formation. Nature 343:657-659.
83. WINNIER, G., BLESSING, M., LABOSKY, P.A. and HOGAN, B.L. (1995). Bone morphogenetic protein-4 is required for mesoderm formation and patterning in the mouse. Genes Dev. 9:2105-2116.
84. WRANA, J.L., ATTISANO, L., WIESER, R., VENTURA, F. and MASSAGUÉ, J. (1994). Mechanism of activation of theTGF-β receptor. Nature 370:341-347.
85. YANG, X., CASTILLA, L.H., XU, X., LI, C., GOTAY, J., WEINSTEIN, M., LIU, P.P. and DENG, C.X. (1999a). Angiogenesis defects and mesenchymal apoptosis in mice lacking SMAD5. Development 126:1571-1580.
86. YANG, X., LETTERIO, J.J., LECHLEIDER. R.J., CHEN, L., HAYMAN, R., GU, H., ROBERTS, A.B. and DENG, C. (1999b). Targeted disruption of SMAD3 results in impaired mucosal immunity and diminished T cell resporisiveness to TGF-β. E.M.B.O. J. 18:1280-1291.
87. YANG, X., LI, C., XU, X. and DENG, C. (1998). The tumor suppressor SMAD4/DPC4 is essential for epiblast proliferation and mesoderm induction in mice. Proc. Natl. Acad. Sci. USA 95:3667-3672.
88. YI, S.E., DALUISKI, A., PEDERSON, R., ROSEN, V. and LYONS, K.M. (2000). The type I BMP receptor BMPRIB is required for chondrogenesis in the mouse limb. Development 127:621-630.
89. ZHANG, H. and BRADLEY, A. (1996). Mice deficient for BMP2 are ncnviable and have defects in amnion/chorion and cardiac development. Development 122:2977-2986.
90. ZHOU, X., SASAKI, H., LOWE, L., HOGAN, B.L. and KUEHN, M.R. (1993). Nodal is a novel TGF-beta-like gene expressed in the mouse node during gastrulation. Nature 361:543-547.
91. ZHU, Y., RICHARDSON, J.A., PARADA, L.F. and GRAFF, J.M. (1998). Smad3 mutant mice develop metastatic colorectal cancer. Cell 94:703-714.